Antidotes Market: Global Industry Analysis and Forecast (2021-2027): by Type, Route of Administration, Application, and Region

Antidotes Market is anticipated to reach US$ 2.61 Bn. by 2027 from US$ 1.6 Bn. in 2020 at a CAGR of 8.5 % during a forecast period. An antidote is a pharmacological or toxicological medicine that is used to counteract the poisonous effects of a toxin. Antidotes work by either changing the chemical composition of the toxin or interfering with the poison's attachment to biological locations.

Antidotes Market Dynamics:

Antidotes have been used since the dawn of medicine. An antidote is a substance that counteracts the effects of a poison or an overdose of another medication. It aids in the neutralization of the harmful effects of a toxin in the body and contains scientific methodologies that have been used to evaluate the therapeutic use of antidotes. The most significant developments include the use of antidotes in the management of poisoning cases that have occurred in recent years. Antidotes Market To know about the Research Methodology:- Request Free Sample Report The market is largely driven by the occurrence of snake bites and the adverse effects associated with them. According to the WHO, around 4.5–5.4 million people are bitten by snakes each year, 1.8–2.7 million of them suffer clinical sickness (envenoming) as a result of the bite, and the death toll might vary from 81,000 to 138,000. This is the primary element driving the growth of the antidotes market. In addition, the increasing occurrence of drug overdose fuels the demand for antidotes. Paracetamol poisoning is the most frequent drug overdose, which can cause liver damage and failure. In addition, the global antidotes market is expected to be driven by increased awareness and research on the identification of toxins of venomous bites by firms and governments to grow to understand antidotes and pharmaceuticals. Antidote demand is being driven by an increase in the occurrence of medical diseases linked to antidotes, such as trichotillomania, toxoplasmosis prophylaxis, smoking cessation, and reversal of sedation, reversal of opioid sedation, pneumocystis pneumonia prophylaxis, and opioid overdose. However, several restrictions in the antidote market, such as the low supply of anti-venoms owing to rising anti-venom costs restricted demand, resulting in treatment declining drastically or even disappearing in some places, are expected to hinder the antidote market’s growth.

Antidotes Market Segmentation Analysis

By Type, Chemical antidotes are the most often used drugs. They exactly engage with and neutralize the poison. Chemical antidotes function by either producing a chemical or converting metabolism. Naloxone hydrochloride is the most often used pharmaceutical antidote for opioid overdose. Antidotes Market 1 By Application, Heavy metal toxicity accounts for a significant portion of the market. The key drivers of category expansion include the increased use of herbal treatments containing heavy metals, as well as rising water contamination. Poisoning with heavy metals is exceedingly dangerous to one's health. Anemia, miscarriages, and early labor are the most prevalent symptoms of heavy metal poisoning. Chelation, or the use of chemical antidotes, is an important part of treatment. Anemia affects 1.62 billion people (95 percent confidence interval: 1.50–1.74 billion), or 24.8 percent of the world's population. As a result, these factors have a function in segment growth.

Antidotes Market Regional Insight

Because of the high incidence of anemia and ongoing research and development initiatives, North America is expected to see revenue growth over the forecast period. Anti-venom manufacturing capacity and awareness of clinical aspects of envenoming, as well as other factors such as higher healthcare spending and improved medical facilities, are driving market growth in the region. Due to technical advances in antidotes, Europe held the second biggest market share in 2020. Due to a growth in the occurrence of medical disorders linked with antidotes such as nerve agent poisoning, methotrexate rescue, methanol poisoning, mercury poisoning, lead poisoning, and gold poisoning, the APAC market is expected to grow at a quick rate. The region's high population density and intensive agricultural operations are also forecast to expand demand for the antidote. The antidote market is dominated by MEA, followed by the Asia Pacific, because of the increasing number of cases detected in these areas. According to the World Health Organization, over 1 million snake bites occur in Africa each year, resulting in 50,000 people needing medical attention, 25,000 fatalities, and another 25,000 people with lasting impairments. The Asia Pacific market is expected to grow rapidly during the forecast period because of an increase in the occurrence of medical problems related to antidotes such as nerve agent poisoning, methotrexate rescue, methanol poisoning, mercury poisoning, lead poisoning, and gold poisoning. These figures are unknown due to a lack of a reliable reporting system in these areas and a failure to report injuries to health care institutions. Due to the high population density and large agricultural operations in the Asia Pacific region, the antidote market is expected to grow significantly throughout the forecast period, boosting demand for antidotes. However, market growth in other regions, such as Latin America, has been disappointing due to a lack of effective snakebite control programs and snakebite management.

Report Objectives:

• Landscape analysis of the Antidotes Market • competitive benchmarking • Past and current status of the industry with the forecasted market size and trends • Evaluation of potential key players that include market leaders, followers, and new entrants • Technology trends • Potential impact of micro-economic factors of the market • External and Internal factors affecting market have been analysed The report also helps in understanding the Antidotes Market dynamics, structure by analysing the market segments and project the Antidotes Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Antidotes Market make the report investor’s guide.

Antidotes Market Scope: Inquire before buying

Antidotes Market
Report Coverage Details
Base Year: 2020 Forecast Period: 2021-2027
Historical Data: 2016 to 2020 Market Size in 2020: US $ 1.6 Bn.
Forecast Period 2021 to 2027 CAGR: 8.5  % Market Size in 2027: US $ 2.61 Bn.
Segments Covered: by Type • Chemical Antidotes • Pharmacological Antidotes • Others
by Route of Administration • Injectable • Oral o Capsules/Tablets o Syrup
by Application • Animal Bites • Heavy Metal Poisoning

Antidotes Market, by Region

• North America • Asia pacific • Europe • Middle East and Africa • South America

Antidotes Market Key Players

Pfizer Inc. • Hikma Pharmaceuticals PLC • Dr. Reddy’s Laboratories Ltd • Aurobindo Pharma • Endo International Inc. • Mylan N.V. • Akorn Incorparated • Alvogen • Fresenius Kabi AG • Zydus Cadila • Daiichi Sanko Inc. • Nichi-Iko Pharmaceutical Co., Ltd • ADAPT Pharma, Inc. • Baxter International, Inc. • Meridian Medical Technologies, Inc. • Novartis AG • Spectrum Pharmaceuticals, Inc.

Frequently Asked Questions

1. What is the projected market size & growth rate of Antidotes Market? Ans- Antidotes Market was valued at USD 1.6 million in 2020 and is projected to reach USD 2.61million by 2027, growing at a CAGR of 8.5 % during the forecast period. 2. What is the key driving factor for the growth of Antidotes Market? Ans- The market is largely driven by the occurrence of snake bites and the adverse effects associated with them. 3. Which Region accounted for the largest Antidotes Market share? Ans- Because of the high incidence of anemia and ongoing research and development initiatives, North America is expected to see revenue growth over the forecast period. 4. What makes North America a Lucrative Market for Antidotes Market? Ans- Anti-venom manufacturing capacity and awareness of clinical aspects of envenoming, as well as other factors such as higher healthcare spending and improved medical facilities, are driving market growth in the region. 5. What are the top players operating in Antidotes Market? Ans- Pfizer Inc., Hikma Pharmaceuticals PLC, Dr. Reddy’s Laboratories Ltd, Aurobindo Pharma, Endo International Inc., and Mylan N.V.
1. Global Antidotes Market: Research Methodology 2. Global Antidotes Market: Executive Summary 2.1 Market Overview and Definitions 2.1.1. Introduction to Global Antidotes Market 2.2. Summary 2.1.1. Key Findings 2.1.2. Recommendations for Investors 2.1.3. Recommendations for Market Leaders 2.1.4. Recommendations for New Market Entry 3. Global Antidotes Market: Competitive Analysis 3.1 MMR Competition Matrix 3.1.1. Market Structure by region 3.1.2. Competitive Benchmarking of Key Players 3.2 Consolidation in the Market 3.2.1 M&A by region 3.3 Key Developments by Companies 3.4 Market Drivers 3.5 Market Restraints 3.6 Market Opportunities 3.7 Market Challenges 3.8 Market Dynamics 3.9 PORTERS Five Forces Analysis 3.10 PESTLE 3.11 Regulatory Landscape by region • North America • Europe • Asia Pacific • The Middle East and Africa • Latin America 3.12 COVID-19 Impact 4. Global Antidotes Market Segmentation 4.1 Global Antidotes Market, By Type (2020-2027) • Chemical Antidotes • Pharmacological Antidotes • Others 4.2 Global Antidotes Market, By Route of Administration (2020-2027) • Injectable • Oral o Capsules/Tablets o Syrup 4.3. European Antidotes Market, By Application (2020-2027) • Animal Bites • Heavy Metal Poisoning 5. North America Antidotes Market (2020-2027) 5.1 North American Antidotes Market, By Type (2020-2027) • Chemical Antidotes • Pharmacological Antidotes • Others 5.2 North America Antidotes Market, By Route of Administration (2020-2027) • Injectable • Oral o Capsules/Tablets o Syrup 5.3. European Antidotes Market, By Application (2020-2027) • Animal Bites • Heavy Metal Poisoning 5.3 North America Antidotes Market, by Country (2020-2027) • United States • Canada • Mexico 6. Asia Pacific Antidotes Market (2020-2027) 6.1. Asia Pacific Antidotes Market, By Type (2020-2027) 6.2. Asia Pacific Antidotes Market, By Route of Administration (2020-2027) 6.3. European Antidotes Market, By Application (2020-2027) 6.4. Asia Pacific Antidotes Market, by Country (2020-2027) • China • India • Japan • South Korea • Australia • ASEAN • Rest Of APAC 7. Middle East and Africa Antidotes Market (2020-2027) 7.1. Middle East and Africa Antidotes Market, By Type (2020-2027) 7.2. Middle East and Africa Antidotes Market, By Route of Administration (2020-2027) 7.3. European Antidotes Market, By Application (2020-2027) 7.4. Middle East and Africa Antidotes Market, by Country (2020-2027) • South Africa • GCC • Egypt • Nigeria • Rest Of ME&A 8. Latin America Antidotes Market (2020-2027) 8.1. Latin America Antidotes Market, By Type (2020-2027) 8.2. Latin America Antidotes Market, By Route of Administration (2020-2027) 8.3. European Antidotes Market, By Application (2020-2027) 8.4 Latin America Antidotes Market, by Country (2020-2027) • Brazil • Argentina • Rest Of Latin America 9. European Antidotes Market (2020-2027) 9.1. European Antidotes Market, By Type (2020-2027) 9.2. European Antidotes Market, By Route of Administration (2020-2027) 9.3. European Antidotes Market, By Application (2020-2027) 9.4 European Antidotes Market, by Country (2020-2027) • UK • France • Germany • Italy • Spain • Sweden • Austria • Rest Of Europe 10. Company Profile: Key players 10.1. Pfizer Inc. 10.1.1. Company Overview 10.1.2. Financial Overview 10.1.3. Global Presence 10.1.4. Capacity Portfolio 10.1.5. Business Strategy 10.1.6. Recent Developments 10.2. Pfizer Inc. 10.3. Hikma Pharmaceuticals PLC 10.4. Dr. Reddy’s Laboratories Ltd 10.5. Aurobindo Pharma 10.6. Endo International Inc. 10.7. Mylan N.V. 10.8. Akorn Incorparated 10.9. Alvogen 10.10. Fresenius Kabi AG 10.11. Zydus Cadila 10.12. Daiichi Sanko Inc. 10.13. Nichi-Iko Pharmaceutical Co., Ltd 10.14. ADAPT Pharma, Inc. 10.15. Baxter International, Inc. 10.16. Meridian Medical Technologies, Inc. 10.17. Novartis AG 10.18. Spectrum Pharmaceuticals, Inc.

About This Report

Report ID 90365
Category Healthcare
Published Date April 2021
Updated Date Dec 2021
Contact Us